E J Lovett - JoVE Visualize

Showing results (11-20 of 34) with videos related to

Pageof 4

Sort By:

Journal of Surgical Oncology|January 1, 1977

Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapyJ Lundy, E J Lovett, D Hinchliffe, et al.

Oncology|January 1, 1982

CAMP differences between clones of high and low malignant fibrosarcoma cellsS Elgebaly, S Kunkel, E J Lovett, et al.

Cancer|March 1, 1978

Halothane, surgery, immunosuppression and artificial pulmonary metastasesJ Lundy, E J Lovett, S Hamilton, et al.

Pediatric Cardiology|January 1, 1993

Gastrointestinal hemorrhage after combined percutaneous angioplasty of aortic coarctation and valvuloplasty of aortic stenosis in an infantJ W Moore, E J Lovett, W C Kirby

Science (New York, N.Y.)|September 5, 1980

Electrical stimulation of the midbrain mediates metastatic tumor growthR H Simon, E J Lovett, D Tomaszek, et al.

Cancer|March 1, 1979

Immune impairment and metastatic tumor growth: the need for an immunorestorative drug as an adjunct to surgeryJ Lundy, E J Lovett, S M Wolinsky, et al.

Surgery|November 1, 1976

Thiabendazole: a potential adjuvant in cancer therapyJ Lundy, E J Lovett, P Conran, et al.

The American Journal of Pathology|November 1, 1980

In vitro and in vivo adherence of tumor cell variants correlated with tumor formationJ Varani, E J Lovett, S Elgebaly, et al.

Journal of the National Cancer Institute|December 1, 1983

Cell surface alpha-D-galactopyranosyl end groups: use as markers in the isolation of murine tumor cell lines with different cancer-causing potentialsJ Varani, E J Lovett, M Wicha, et al.

Cardiovascular and Interventional Radiology|September 1, 1991

Use of an intravascular endoprosthesis (stent) to establish and maintain short-term patency of the ductus arteriosus in newborn lambsJ W Moore, W C Kirby, E J Lovett, et al.

Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:

Pageof 4

Journal of Surgical Oncology|January 1, 1977

Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapyJ Lundy, E J Lovett, D Hinchliffe, et al.

Oncology|January 1, 1982

CAMP differences between clones of high and low malignant fibrosarcoma cellsS Elgebaly, S Kunkel, E J Lovett, et al.

Cancer|March 1, 1978

Halothane, surgery, immunosuppression and artificial pulmonary metastasesJ Lundy, E J Lovett, S Hamilton, et al.

Pediatric Cardiology|January 1, 1993

Gastrointestinal hemorrhage after combined percutaneous angioplasty of aortic coarctation and valvuloplasty of aortic stenosis in an infantJ W Moore, E J Lovett, W C Kirby

Science (New York, N.Y.)|September 5, 1980

Electrical stimulation of the midbrain mediates metastatic tumor growthR H Simon, E J Lovett, D Tomaszek, et al.

Cancer|March 1, 1979

Immune impairment and metastatic tumor growth: the need for an immunorestorative drug as an adjunct to surgeryJ Lundy, E J Lovett, S M Wolinsky, et al.

Surgery|November 1, 1976

Thiabendazole: a potential adjuvant in cancer therapyJ Lundy, E J Lovett, P Conran, et al.

The American Journal of Pathology|November 1, 1980

In vitro and in vivo adherence of tumor cell variants correlated with tumor formationJ Varani, E J Lovett, S Elgebaly, et al.

Journal of the National Cancer Institute|December 1, 1983

Cell surface alpha-D-galactopyranosyl end groups: use as markers in the isolation of murine tumor cell lines with different cancer-causing potentialsJ Varani, E J Lovett, M Wicha, et al.

Cardiovascular and Interventional Radiology|September 1, 1991

Use of an intravascular endoprosthesis (stent) to establish and maintain short-term patency of the ductus arteriosus in newborn lambsJ W Moore, W C Kirby, E J Lovett, et al.

Pageof 4